SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-24-003716
Filing Date
2024-03-21
Accepted
2024-03-21 17:21:31
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A krbp-20231231x10ka.htm   iXBRL 10-K/A 362004
2 EX-31.1 krbp-20231231xex31d1.htm EX-31.1 6028
3 EX-31.2 krbp-20231231xex31d2.htm EX-31.2 6112
  Complete submission text file 0001558370-24-003716.txt   636063

Data Files

Seq Description Document Type Size
4 EX-101.SCH krbp-20231231.xsd EX-101.SCH 4273
5 EX-101.DEF krbp-20231231_def.xml EX-101.DEF 32925
6 EX-101.LAB krbp-20231231_lab.xml EX-101.LAB 26409
7 EX-101.PRE krbp-20231231_pre.xml EX-101.PRE 16688
20 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20231231x10ka_htm.xml XML 8699
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39619 | Film No.: 24772393
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)